Literature DB >> 23266514

Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus.

Oriana S Fisher1, Rong Zhang, Xiaofeng Li, James W Murphy, Borries Demeler, Titus J Boggon.   

Abstract

Cerebral cavernous malformations (CCM) are neurovascular dysplasias affecting up to 0.5% of the population. Mutations in the CCM2 gene are associated with acquisition of CCM. We identify a previously uncharacterized domain at the C-terminus of CCM2 and determine its 1.9Å resolution crystal structure. Because this domain is structurally homologous to the N-terminal domain of harmonin, we name it the CCM2 harmonin-homology domain or HHD. CCM2 HHD is observed in two conformations, and we employ analytical ultracentrifugation to test its oligomerization. Additionally, CCM2 HHD contains an unusually long 13-residue 3(10) helix. This study provides the first structural characterization of CCM2.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266514      PMCID: PMC3558538          DOI: 10.1016/j.febslet.2012.12.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.

Authors:  Mark T Uhlik; Amy N Abell; Nancy L Johnson; Weiyong Sun; Bruce D Cuevas; Katherine E Lobel-Rice; Eric A Horne; Mark L Dell'Acqua; Gary L Johnson
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

2.  3(10)-helices in proteins are parahelices.

Authors:  Purevjav Enkhbayar; Kunio Hikichi; Mitsuru Osaki; Robert H Kretsinger; Norio Matsushima
Journal:  Proteins       Date:  2006-08-15

3.  Shape complementarity at protein/protein interfaces.

Authors:  M C Lawrence; P M Colman
Journal:  J Mol Biol       Date:  1993-12-20       Impact factor: 5.469

4.  CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.

Authors:  Jon S Zawistowski; Lisa Stalheim; Mark T Uhlik; Amy N Abell; Brooke B Ancrile; Gary L Johnson; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2005-07-21       Impact factor: 6.150

5.  The structural determination of an insect sterol carrier protein-2 with a ligand-bound C16 fatty acid at 1.35-A resolution.

Authors:  David H Dyer; Scott Lovell; James B Thoden; Hazel M Holden; Ivan Rayment; Que Lan
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

6.  Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.

Authors:  Amy L Akers; Eric Johnson; Gary K Steinberg; Joseph M Zabramski; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

7.  Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.

Authors:  Sonja Stahl; Sabine Gaetzner; Katrin Voss; Bettina Brackertz; Elisa Schleider; Oguzkan Sürücü; Ekkehard Kunze; Christian Netzer; Christoph Korenke; Ulrich Finckh; Mario Habek; Zdravka Poljakovic; Miriam Elbracht; Sabine Rudnik-Schöneborn; Helmut Bertalanffy; Ulrich Sure; Ute Felbor
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

8.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

9.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more
  19 in total

Review 1.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

2.  Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.

Authors:  Souvik Kar; Kiran Kumar Bali; Arpita Baisantry; Robert Geffers; Amir Samii; Helmut Bertalanffy
Journal:  J Mol Neurosci       Date:  2017-02-08       Impact factor: 3.444

Review 3.  PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.

Authors:  Souvik Kar; Amir Samii; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2014-11-19       Impact factor: 3.042

4.  Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.

Authors:  Oriana S Fisher; Weizhi Liu; Rong Zhang; Amy L Stiegler; Sondhya Ghedia; James L Weber; Titus J Boggon
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

Review 5.  Cerebral cavernous malformation proteins at a glance.

Authors:  Kyle M Draheim; Oriana S Fisher; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2014-01-30       Impact factor: 5.285

Review 6.  Vis-à-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis.

Authors:  Concetta Scimone; Luigi Donato; Silvia Marino; Concetta Alafaci; Rosalia D'Angelo; Antonina Sidoti
Journal:  Neurol Sci       Date:  2018-12-06       Impact factor: 3.307

Review 7.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

8.  Structural analysis of the KRIT1 ankyrin repeat and FERM domains reveals a conformationally stable ARD-FERM interface.

Authors:  Rong Zhang; Xiaofeng Li; Titus J Boggon
Journal:  J Struct Biol       Date:  2015-10-14       Impact factor: 2.867

9.  Structural basis of the strict specificity of a bacterial GH31 α-1,3-glucosidase for nigerooligosaccharides.

Authors:  Marina Ikegaya; Toshio Moriya; Naruhiko Adachi; Masato Kawasaki; Enoch Y Park; Takatsugu Miyazaki
Journal:  J Biol Chem       Date:  2022-03-12       Impact factor: 5.486

10.  Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex.

Authors:  Oriana S Fisher; Hanqiang Deng; Dou Liu; Ya Zhang; Rong Wei; Yong Deng; Fan Zhang; Angeliki Louvi; Benjamin E Turk; Titus J Boggon; Bing Su
Journal:  Nat Commun       Date:  2015-08-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.